Orion Infusion Limited reported unaudited earnings results for the third quarter and nine months ended March 31, 2017. For the quarter, the company reported EPS of BDT 0.46 against BDT 0.29 a year ago. For the nine months, the company reported EPS of BDT 1.14 against BDT 1.89 a year ago. NOCFPS was BDT 0.92 against BDT 0.22 a year ago. NAV per share was BDT 12.79 as of March 31, 2017 and BDT 12.98 as of June 30, 2016.